Multidisciplinary Tumour Board Case Presentations ~ Multidisciplinary Approaches in Esophageal Cancer Treatment

The session presents a multidisciplinary tumor board approach to esophageal cancer. Discussions include the importance of biopsies for accurate staging, treatment options like neoadjuvant chemotherapy, and global perspectives on management strategies. Prognostic features, immunotherapy considerations, and endoscopic treatment responses are examined, alongside recommendations for surgery and patient empowerment techniques. Medical…

Continue reading

Late Breaking Oral Abstracts: Clinical Trials in Esophageal Cancer

Clinical trials in esophageal cancer reveal that robotic surgery outperforms traditional methods, enhancing lymph node clearance and minimizing complications. The importance of surgeon experience and neoadjuvant treatment is discussed. Additionally, a study shows that 46% of patients experience poor health-related quality of life, with specific symptoms identified. The need for…

Continue reading

Preventing/Managing Complications in the Management of Esophageal Cancer Patients – ISDE-AUGIS Combined Session

Preventing and managing complications in esophageal cancer patients is crucial, especially regarding conduit issues like leaks and necrosis. The session emphasizes careful patient selection and prevention strategies, while also discussing historical methodologies and the need for standardized treatment approaches. Surgical techniques are explored, focusing on visual feedback and managing complications,…

Continue reading

Achalasia: From Diagnosis to Treatment to Surveillance

The session covers achalasia, focusing on its epidemiology, misdiagnosis, and advancements in diagnosis and treatment. It highlights the importance of endoscopy and the Car Scoring System for accurate diagnosis. Various assessment techniques and treatment options for dysphagia, including pneumatic dilation and surgical interventions, are discussed. The impact of esophageal sensitivity…

Continue reading

Esophageal Squamous Cell Carcinoma (ESCC): From Stage I to IV – JES-ISDE Session

Management of stage one esophageal squamous cell carcinoma focuses on effective treatment strategies. Endoscopic resection is highlighted as a minimally invasive option with high success rates. Long-term outcomes show promising survival rates. Stricture prevention methods are compared, and guidelines emphasize treatment based on lesion characteristics. Clinical trials indicate chemoradiotherapy is…

Continue reading

Video Session: Esophageal Oncology Surgery

Participants introduce themselves and discuss minimally invasive surgery, highlighting its techniques and significance. They review clinical trials comparing outcomes of minimally invasive and open surgeries, focusing on morbidity and mortality rates. Robotic surgery techniques are demonstrated, showing their application and effectiveness. The session concludes with insights into hybrid surgical techniques…

Continue reading

Diseases of the Esophagus Festival

The Esophagus Journal Festival showcases its new editorial team focusing on quality and diversity. Award winners were announced, and presentations delivered on the top manuscripts published in 2023 including: Performance of a consensus-based algorithm for diagnosing anastomotic leak after minimally invasive esophagectomy for esophageal cancer presented by Jobbe Lemmens, Department of…

Continue reading

Locally Advanced Esophageal Cancer – Beyond Clinical Trials

Locally advanced esophageal cancer, particularly adenocarcinoma, is increasingly diagnosed in patients under 50, with a notable rise in cases among black and Hispanic individuals. The session discusses treatment challenges, survival outcomes, and the need for biomarker testing. It reviews neoadjuvant and adjuvant treatment trials, including the JO 1 8 0…

Continue reading

Researching The Use Biomarkers for Managing Barrett’s Esophagus

Watch Dr. David Lui interview Professor Sheila K. Krishnadath discuss the recent approval of a research project focusing on biomarkers. The grant is the culmination of many years of research looking at biomarkers as a means of making clinical decisions for managing Barrett’s esophagus. Up until now this research has…

Continue reading